Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EZH2 | Q15910 | 8/20 | 0.43 |
| ▸ | EZH1 | Q92800 | 2/20 | 0.42 |
| ▸ | EED | O75530 | 1/20 | 0.41 |
| ▸ | RBBP4 | Q09028 | 1/20 | 0.41 |
| ▸ | SUZ12 | Q15022 | 1/20 | 0.41 |
| ▸ | AEBP2 | Q6ZN18 | 1/20 | 0.41 |
| ▸ | PDE9A | O76083 | 7/20 | 0.40 |
| ▸ | PDE1C | Q14123 | 3/20 | 0.38 |
| ▸ | PDE1A | P54750 | 2/20 | 0.38 |
| ▸ | PDE1B | Q01064 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18800384 | 0.89 | PDE9A (0.45) | EZH2EZH1PDE9APDE1C | |
| SCHEMBL12684462 | 0.88 | EZH2 (0.51) | EZH2EZH1EEDRBBP4SUZ12 | |
| SCHEMBL18800353 | 0.87 | EZH1 (0.42) | EZH2EZH1PDE9APDE1CPDE1A | |
| SCHEMBL18800350 | 0.84 | EZH2 (0.54) | EZH2EZH1EEDRBBP4SUZ12 | |
| SCHEMBL18800352 | 0.84 | EZH1 (0.43) | EZH2EZH1PDE9APDE1C | |
| SCHEMBL18800382 | 0.83 | EZH1 (0.44) | EZH2EZH1PDE9APDE1C | |
| SCHEMBL18800379 | 0.81 | EZH1 (0.42) | EZH2EZH1EEDRBBP4SUZ12 | |
| SCHEMBL18800424 | 0.80 | EZH1 (0.41) | EZH2EZH1PDE9APDE1C | |
| SCHEMBL12684507 | 0.76 | EZH2 (0.57) | EZH2EZH1EEDRBBP4SUZ12 | |
| SCHEMBL12684442 | 0.75 | EZH1 (0.52) | EZH2EZH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9637472-B2 | Substituted 6,5-fused bicyclic heteroaryl compounds | Epizyme, Inc. (US) | 2017-05-02 | — | — | US | disclosed |